flumazenil has been researched along with Epidermolysis Bullosa Junctionalis, Disentis Type in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mayer, B | 1 |
| Silló, P | 1 |
| Mazán, M | 1 |
| Pintér, D | 1 |
| Medvecz, M | 1 |
| Has, C | 1 |
| Castiglia, D | 1 |
| Petit, F | 1 |
| Charlesworth, A | 1 |
| Hatvani, Z | 1 |
| Pamjav, H | 1 |
| Kárpáti, S | 1 |
1 other study available for flumazenil and Epidermolysis Bullosa Junctionalis, Disentis Type
| Article | Year |
|---|---|
A unique LAMB3 splice-site mutation with founder effect from the Balkans causes lethal epidermolysis bullosa in several European countries.
Topics: Amino Acid Substitution; Cell Adhesion Molecules; DNA, Complementary; Emigration and Immigration; Ep | 2016 |